Related Experiment Video
Updated: Apr 22, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
Published on: October 17, 2025
Activity-dependent FUS dysregulation disrupts synaptic homeostasis
Chantelle F Sephton1, Amy A Tang2, Ashwinikumar Kulkarni3
1Departments of Neuroscience and Institut Universitaire en Santé Mentale de Québec, Department of Psychiatry and Neuroscience, Université Laval, Quebec City, QC, Canada G1J 2G3; Chantelle.Sephton.1@ulaval.ca Gang.Yu@UTSouthwestern.edu.
Transgenic mice expressing mutated fused-in-sarcoma (FUS) protein develop neurodegenerative disease, including motor deficits and neuroinflammation. These models reveal FUS
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- The RNA-binding protein fused-in-sarcoma (FUS) is implicated in neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).
- Both FUS mutations and overexpression of wild-type FUS can lead to disease pathogenesis in humans.
Purpose of the Study:
- To investigate the molecular and cellular mechanisms underlying FUS-associated neurodegenerative diseases.
- To create and characterize novel transgenic mouse models expressing wild-type (FUS(WT)) and mutant (FUS(R521G)) human FUS protein.
Main Methods:
- Generation of transgenic mice globally expressing low levels of human FUS(WT) and FUS(R521G).
- Phenotypic analysis including motor function, neuroinflammation, neuromuscular junction integrity, and survival rates.
- Assessment of dendritic arborization and spine density in FUS(R521G) 'escaper' mice.
- Biochemical analysis of FUS protein levels in response to metabotropic glutamate receptor activation.
Main Results:
- Both FUS(WT) and FUS(R521G) mice exhibit motor deficits, neuroinflammation, denervated neuromuscular junctions, and premature death, mimicking human ALS/FTLD.
- FUS(R521G) 'escaper' mice show reduced motor function, altered sociability, and decreased dendritic arbors and spines, unlike FUS(WT) mice.
- Activation of metabotropic glutamate receptors differentially affects FUS(R521G) and FUS(WT)/endogenous FUS protein levels, potentially explaining dendritic defects.
Conclusions:
- Transgenic mouse models expressing FUS(WT) and FUS(R521G) effectively recapitulate key features of FUS-associated neurodegenerative disorders.
- The FUS(R521G) mutation specifically induces dendritic spine abnormalities, suggesting distinct pathogenic mechanisms compared to FUS overexpression alone.
- Differential regulation of FUS protein by glutamate receptor signaling may contribute to the observed synaptic pathology in FUS(R521G) mice.
More Related Videos
08:59Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
07:43Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Long-term Depression
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...